Urinary Tract Infection News and Research

Urinary tract infections are a serious health problem affecting millions of people each year. Infections of the urinary tract are the second most common type of infection in the body. Urinary tract infections (UTIs) account for about 8.3 million doctor visits each year.* Women are especially prone to UTIs for reasons that are not yet well understood. One woman in five develops a UTI during her lifetime. UTIs in men are not as common as in women but can be very serious when they do occur.

System to help identify patients at high risk of developing delirium

19. November 2009 06:23

A specialist in caring for elderly patients, Turner-Hubbard is a geriatric nurse practitioner trained to quickly spot the sudden changes in mental status that signal the onset of the sudden, severe confusion known as delirium. She knows the hospital “triggers” that can bring on fluctuations in behavior: blood loss during surgery, anesthesia, pain medications and anti-anxiety drugs, infections, dehydration, IV lines and catheters, as well as being immobilized for an extended period of time. [More]

a5cec3eb-8d98-4cc7-a4a3-1877f23cd72d|0|.0

Posted in: Device / Technology News | Medical Condition News

Tags: Anxiety, Brain, Cancer, Catheter, Dehydration, Delirium, Dementia, Hospital, Intensive Care, Nursing, Orthopedic, Sleep, Speech, Urinary Tract Infection

Hospitals should expand quality control guidelines to improve surgical complications in older patients

17. November 2009 02:00

The elderly are more vulnerable to problems after a major surgical procedure than younger patients, but a team of investigators using data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) suggest that one way to improve surgical results in this age group is to have hospitals expand their quality control guidelines to include more types of surgery-related complications. [More]

55298a75-c808-4e25-af29-ea70061ab2d3|0|.0

Posted in: Healthcare News

Tags: Hospital, Pneumonia, Pulmonary Embolism, Renal Failure, Urinary Tract Infection

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

19. October 2009 23:55

UCB today announced data that showed rapid and sustained improvements in ACR20, physical function, pain and fatigue of rheumatoid arthritis (RA) as early as the first week, and inhibition of progression of structural joint damage (seen at week 24) following treatment with Cimzia (certolizumab pegol), together with methotrexate (MTX), was sustained up to 100 weeks. [More]

9fa30521-bee5-4c51-87b2-372a20331b94|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Abatacept, Anemia, Angioedema, Antibody, Anti-Inflammatory, Arthralgia, Arthritis, Autoimmune Disease, Back Pain, Bone, Bronchitis, Cancer, Congestive Heart Failure, Crohn's Disease, Dyspnea, Exercise, Headache, Heart Failure, Hepatitis B, Hospital, Hypersensitivity, Immunology, Leukopenia, Listeriosis, Lupus, Lymphoma, Melanoma, Methotrexate, Nervous System, Neuropathy, Rheumatoid Arthritis, Rheumatology, Rituximab, Sepsis, Skin Cancer, Thrombocytopenia, TNF Blockers, Tuberculosis, Urinary Tract Infection, Urticaria, Virus

Genentech reports results of ACTEMRA Phase III study for rheumatoid arthritis

19. October 2009 07:43

Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis (RA) who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA® (tocilizumab), in combination with methotrexate, had no progression of joint damage, (75 and 83 percent, respectively, as assessed by radiograph) compared with people who received methotrexate alone (66 percent). [More]

03526c26-c2ce-4a73-bb21-9ff19457eeb3|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Antibody, Arthritis, Autoimmune Disease, Biotechnology, Bronchitis, Cellulitis, Cholesterol, Cytokines, Gastroenteritis, Headache, Hygiene, Hypersensitivity, Interleukin-6, Life Expectancy, Lipids, Methotrexate, Monoclonal Antibody, Osteoporosis, Pneumonia, Rheumatoid Arthritis, Rheumatology, Urinary Tract Infection

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

15. October 2009 02:58

A study, published online in the journal Current Medical Research and Opinion, showed that a greater percentage of patients with type 2 diabetes treated with the fixed-dose combination ACTOplus met® (pioglitazone HCl and metformin HCl) as initial therapy reached the study goal of hemoglobin A1c (HbA1c) of less than or equal to 7 percent compared to either component alone. [More]

fc68e94e-d90a-4228-82e2-97e607cc13a3|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Actos, Anemia, Bone, Breastfeeding, Cardiovascular Disease, Diabetes, Diabetic Ketoacidosis, Diarrhea, Diet, Exercise, Gastroenterology, Headache, Heart Failure, Hospital, Hypersensitivity, Insomnia, Insulin, Insulin Resistance, Kidney Disease, Metformin, Nausea, Neurology, Pioglitazone, Rheumatology, Sore Throat, Sulfonylurea, Type 2 Diabetes, Urinary Tract Infection, Vomiting

MEDai to implement Pinpoint Review at Sharp HealthCare

14. October 2009 06:19

MEDai, Inc., an Elsevier company and leading provider of advanced healthcare solutions including hospital outcomes analysis and award-winning predictive analytics, has announced that Sharp HealthCare, a 1,700-bed, seven-facility system serving the San Diego area, has selected the company's Pinpoint Review(TM) product. [More]

d1d75366-0e4a-4234-8484-6486b59da6c3|0|.0

Posted in: Device / Technology News | Healthcare News

Tags: Cell, Hospital, Nursing, Urinary Tract Infection

Studies show that physiotherapy can help relieve symptoms of prostatitis

14. October 2009 03:18

Prostatitis is no picnic. It is a urological condition which causes infection or inflammation of the prostate gland. It is a fairly common health concern, especially for men under 50 and can seriously affect quality of life including sexuality and intimate relationships. However, new research regarding the benefits of physiotherapy in treating prostititis is promising. [More]

52197dd1-1b1f-468f-bcaa-4cc69c0a1cce|0|.0

Posted in: Men's Health News

Tags: Arthritis, Back Pain, Education, Exercise, Hospital, Incontinence, Physical Therapy, Physiotherapy, Prostatitis, Sexual Dysfunction, Urinary Tract Infection, Urology

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

24. September 2009 05:35

Merck & Co., Inc. and QIAGEN N.V. today announced their intent to collaborate on a new program to increase access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world. [More]

51b902cb-1ff2-4dd3-868d-e1bc7189ee80|0|.0

Posted in: Women's Health News | Pharmaceutical News

Tags: Abortion, Anemia, Antibody, Appendicitis, Arrhythmia, Arthralgia, Asthma, Biotechnology, Cancer, Cell, Cervical Cancer, Cervical Intraepithelial Neoplasia, DNA, Dysplasia, Eclampsia, Education, Fertility, Gardasil, Gastroenteritis, Headache, Hepatitis B, Hypersensitivity, Hyperthyroidism, Immunization, Inflammatory Disease, Leukemia, Lupus, Nausea, Nervous System, Neuron, Nursing, Pancreatic Cancer, Pancreatitis, Paralysis, Pelvic Inflammatory Disease, Pharmacology, Pneumonia, Pre-eclampsia, Pregnancy, Proteomics, Pulmonary Embolism, Renal Failure, Sepsis, Squamous Cell Carcinoma, Stenosis, Thrombosis, Toxicology, Tuberculosis, Urinary Tract Infection, Urticaria, Vaccine, Vaginal Cancer, Virus, Vomiting

FDA approves Valturna tablets for treating high blood pressure

18. September 2009 02:19

The US Food and Drug Administration (FDA) has approved Valturna((R)) (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS), an important regulator of blood pressure. [More]

24018f47-8d6b-46ba-b544-a2de3e9a72ff|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Abdominal Pain, Aldosterone, Angiotensin, Blood Pressure, Cancer, Cough, Cyclosporine, Dialysis, Diarrhea, Diet, Heart Failure, Low Blood Pressure, Nervous System, Potassium, Renin, Sore Throat, Stroke, Urinary Tract Infection, Vomiting

Medicare Advantage's preventive health care strategy keeps seniors out of the hospital

16. September 2009 04:47

Seniors in Medicare Advantage spent fewer days in a hospital, were subject to fewer hospital re-admissions, and were less likely to have "potentially avoidable" admissions, for common conditions ranging from uncontrolled diabetes to dehydration, according to a new analysis of publicly available AHRQ data released today by America's Health Insurance Plans (AHIP). [More]

855a379d-dccd-4436-b35c-40adca86f89e|0|.0

Posted in:

Tags: Dehydration, Diabetes, Health Insurance, Hospital, Medicare, Seniors, Urinary Tract Infection

Extension study data on Fampridine-SR drug

15. September 2009 07:55

Data from two long-term open-label extension studies of Fampridine-SR show that 86.0% of participants remained on therapy after a maximum treatment time of 15 months in study MS-F204EXT, and 69.5% remained on therapy after a maximum treatment time of 36 months in study MS-F203EXT. [More]

fe037785-f701-429b-a5a9-1bf85931c897|0|.0

Posted in: Drug Trial News

Tags: Arthralgia, Biotechnology, Brain, Multiple Sclerosis, Myelin, Nervous System, New Drug Application, Spinal Cord Injury, Urinary Tract Infection

HHS Secretary to issue new report on the employer-sponsored insurance market

11. September 2009 06:37

HHS Secretary Kathleen Sebelius today will address the University of Chicago’s dialogue on health care reform and education and issue a new report on the employer-sponsored insurance market. [More]

7317c292-b83a-45b7-8fe0-999c93ba0ec3|0|.0

Posted in: Healthcare News

Tags: Cancer, Disinfectant, Education, Health Insurance, Health Reform, Hospital, Medicaid, Medical Errors, Medicare, Pfizer, Pneumonia, Seniors, Urinary Tract Infection

Acorda Therapeutics announces Phase 3 Fampridine-SR trial findings

10. September 2009 06:54

Data from a long-term open-label extension study from the first Phase 3 Fampridine-SR trial, known as MS-F203, showed that 24.9% of extension study participants with multiple sclerosis (MS) met the criteria as Extension Timed Walk Responders (ETWRs) after one year of treatment and demonstrated improved walking speed over a two year period. [More]

d62d128d-481d-4c76-b8da-4b7a8edcfee8|1|1.0

Posted in: Drug Trial News

Tags: Arthralgia, Biotechnology, Brain, Cellulitis, Multiple Sclerosis, Myelin, Nervous System, New Drug Application, Spinal Cord Injury, Urinary Tract Infection

Merck's GARDASIL receives approval from FDA Advisory Committee

10. September 2009 00:48

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11. [More]

a61cc048-e575-419e-a185-90b4d9042453|1|5.0

Posted in: Pharmaceutical News

Tags: Abortion, Anemia, Antibody, Appendicitis, Arrhythmia, Arthralgia, Asthma, Cancer, Cell, Cervical Cancer, Cervical Intraepithelial Neoplasia, DNA, Dysplasia, Eclampsia, Fertility, Gardasil, Gastroenteritis, Headache, Hepatitis B, Hypersensitivity, Hyperthyroidism, Immunization, Inflammatory Disease, Leukemia, Lupus, Nausea, Nervous System, Neuron, Nursing, Pancreatic Cancer, Pancreatitis, Paralysis, Pelvic Inflammatory Disease, Pharmacology, Pneumonia, Pre-eclampsia, Pregnancy, Pulmonary Embolism, Renal Failure, Sepsis, Squamous Cell Carcinoma, Stenosis, Thrombosis, Toxicology, Tuberculosis, Urinary Tract Infection, Urticaria, Vaccine, Vaginal Cancer, Virus, Vomiting

Urodynamics equipment and disposables report from Reportlinker

9. September 2009 06:20

Reportlinker.com announces that a new market research report is available in its catalogue: Urodynamics Equipment and Disposables [More]

a1a6f225-5532-4315-a2c1-6f76d292fee9|0|.0

Posted in: Device / Technology News

Tags: Benign Prostatic Hyperplasia, Catheter, Incontinence, Stent, Stress, Ultrasound, Urinary Incontinence, Urinary Tract Infection

<< Previous posts

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Urinary Tract Infection News and Research

System to help identify patients at high risk of developing delirium

Hospitals should expand quality control guidelines to improve surgical complications in older patients

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

Genentech reports results of ACTEMRA Phase III study for rheumatoid arthritis

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

MEDai to implement Pinpoint Review at Sharp HealthCare

Studies show that physiotherapy can help relieve symptoms of prostatitis

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

FDA approves Valturna tablets for treating high blood pressure

Medicare Advantage's preventive health care strategy keeps seniors out of the hospital

Extension study data on Fampridine-SR drug

HHS Secretary to issue new report on the employer-sponsored insurance market

Acorda Therapeutics announces Phase 3 Fampridine-SR trial findings

Merck's GARDASIL receives approval from FDA Advisory Committee

Urodynamics equipment and disposables report from Reportlinker

Recent Articles

Free!

Recent Comments

Twitter

Information

Urinary Tract Infection News and Research

Medical News Cloud

Recent Articles